BioBridge Global recently gave a tour of subsidiary GenCure to Blood Centers of America Advanced Therapies Network.
The tour showcased GenCure’s cGMP biomanufacturing facility and process development laboratory capabilities.
BioBridge Global also supports advanced therapies with cellular therapy testing services and collections of starting materials.
Scott Jones, Chief Scientific Officer at BioBridge Global, also presented on the importance of testing of starting materials and therapeutic products at a BCA workshop held the previous day.
BioBridge Global is a partner and member of BCA, which comprises more than 60 independent blood centers and represents 50% of the U.S. blood supply.